Electroacupuncture for Postoperative Ileus After Laparoscopic Rectal Cancer Surgery

February 10, 2014 updated by: Simon S. M. Ng, Chinese University of Hong Kong

Can Electroacupuncture Prevent Prolonged Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer? A Prospective Study With Matched Historical Controls

Postoperative ileus remains a significant medical problem after colorectal surgery that adversely influences patients' recovery. The investigators previous study demonstrated that electroacupuncture (EA) at Zusanli, Sanyinjiao, Hegu, and Zhigou reduces the duration of postoperative ileus and hospital stay after laparoscopic resection of colonic and upper rectal cancer. Patients with mid/low rectal cancer undergoing laparoscopic total mesorectal excision (TME) or abdominoperineal resection (APR) were excluded. However, these complex cases are more likely to develop prolonged ileus and morbidity after surgery, and it is uncertain whether EA will be beneficial to them. The investigators therefore propose to conduct a prospective cohort study to evaluate the efficacy of EA in preventing prolonged ileus after laparoscopic surgery for mid/low rectal cancer. Fifty consecutive patients with mid/low rectal cancer undergoing laparoscopic TME or APR without the need of conversion will be recruited. All patients will undergo 1 session (20 minutes) of EA daily from postoperative day 1 till day 4. These patients will be compared with a matched historical control group (1:2) who underwent laparoscopic TME or APR without EA. The primary outcome is the incidence of prolonged ileus, which is defined as the inability to tolerate fluid diet by 4 days after surgery, associated with the need for nasogastric decompression and/or parenteral nutrition support. Secondary outcomes include time to defecation and duration of hospital stay. Results of this study will help clarify the efficacy of EA in preventing prolonged ileus after laparoscopic rectal surgery, and may provide the basis for planning a larger randomized controlled trial.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Hong Kong SAR, China
        • Recruiting
        • Prince of Wales Hospital, The Chinese University of Hong Kong
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Wing Wa Leung, MSc
        • Sub-Investigator:
          • Tony WC Mak, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consecutive patients (aged between 18 and 80) with mid/low rectal cancer undergoing laparoscopic TME or APR without the need of conversion
  • Patients with American Society of Anesthesiologists grading I-III
  • Informed consent available

Exclusion Criteria:

  • Patients undergoing simultaneous laparoscopic resection of rectal cancer and other coexisting intraabdominal diseases
  • Patients undergoing laparoscopic resection of rectal cancer with en-bloc resection of surrounding organs
  • Patients who developed intraoperative problems or complications (e.g. bleeding, tumor perforation) that required conversion
  • Patients with intestinal obstruction
  • Patients with previous history of abdominal surgery
  • Patients with evidence of peritoneal carcinomatosis
  • Patients who are expected to receive epidural anesthesia or analgesia
  • Patients with cardiac pacemaker
  • Patients who are pregnant
  • Patients who are allergic to acupuncture needles

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Electroacupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of prolonged ileus
Time Frame: Up to 1 month
Defined as the inability to tolerate fluid diet by 4 days after surgery, associated with the need for nasogastric decompression and/or parenteral nutrition support.
Up to 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of first passing flatus reported by the patients
Time Frame: Up to 1 month
Up to 1 month
Time to first defecation
Time Frame: Up to 1 month
Up to 1 month
Time that the patients tolerated solid diet
Time Frame: Up to 1 month
Up to 1 month
Duration of hospital stay
Time Frame: Up to 1 month
Up to 1 month
Pain scores on visual analog scale
Time Frame: Up to 3 days
From 0 which implies no pain at all, to 10 which implies the worst pain imaginable
Up to 3 days
Postoperative analgesic requirement
Time Frame: Up to 1 month
Up to 1 month
Overall complication rate
Time Frame: Up to 1 month
Up to 1 month
30-day mortality rate
Time Frame: Up to 1 month
Up to 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Anticipated)

May 1, 2014

Study Completion (Anticipated)

May 1, 2014

Study Registration Dates

First Submitted

April 24, 2013

First Submitted That Met QC Criteria

May 2, 2013

First Posted (Estimate)

May 3, 2013

Study Record Updates

Last Update Posted (Estimate)

February 11, 2014

Last Update Submitted That Met QC Criteria

February 10, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • CRE-2013.032

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Ileus

Clinical Trials on Electroacupuncture

3
Subscribe